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Abstract
Since the discovery of antibiotics in the first quarter of the twentieth century, their use has been the principal approach to 
treat bacterial infection. Modernized medicine such as cancer therapy, organ transplantation or advanced major surgeries 
require effective antibiotics to manage bacterial infections. However, the irresponsible use of antibiotics along with the lack 
of development has led to the emergence of antimicrobial resistance which is considered a serious global threat due to the 
rise of multidrug-resistant bacteria (Wang et al. in Antibiotic resistance: a rundown of a global crisis, pp. 1645–1658, 2018). 
Currently employed diagnostics techniques are microscopy, colony counting, ELISA, PCR, RT-PCR, surface-enhanced 
Raman scattering and others. These techniques provide satisfactory selectivity and sensitivity (Joung et al. in Sens Actuators 
B Chem 161:824–831, 2012). Nevertheless, they demand specialized personnel and expensive and sophisticated machinery 
which can be labour-intensive and time-consuming, (Malvano et al. in Sensors (Switzerland) 18:1–11, 2018; Mantzila et al. 
in Anal Chem 80:1169–1175, 2008). To get around these problems, new technologies such as biosensing and lab-on-a-chip 
devices have emerged in the last two decades. Impedimetric immunosensors function by applying electrochemical imped-
ance spectroscopy to a biosensor platform using antibodies or other affinity proteins such as Affimers (Tiede et al. in Elife 
6(c):1–35, 2017) or other binding proteins (Weiss et al. in Electrochim Acta 50:4248–4256, 2005) as bioreceptors, which 
provide excellent sensitivity and selectivity. Pre-enrichment steps are not required and this allows miniaturization and low-
cost. In this review different types of impedimetric immunosensors are reported according to the type of electrode and their 
base layer materials, either self-assembled monolayers or polymeric layers, composition and functionalization for different 
types of bacteria, viruses, fungi and disease biomarkers. Additionally, novel protein scaffolds, both antibody derived and 
non-antibody derived, used to specifically target the analyte are considered.
Keywords Biosensor · Electrochemical impedance spectroscopy (EIS) · Immunosensor · Bacteria · Virus · Biomarker
Introduction
Several worldwide leading healthcare organizations such 
as the Centers for Disease Control and Prevention (CDC), 
Infectious Diseases Society of America and the WHO have 
asserted that antibiotic resistance is a global public threat. 
Evolution of pathogens along with human beings is a bur-
den and resistance to antibiotics and antivirals are becoming 
widespread. Several studies reveal that around the 30–50% 
of antibiotic treatments are inappropriate in the USA, where 
antibiotic-resistant hospital acquired infections (HAIs) are 
responsible for 99,000 deaths annually [1]. According to 
O’Neill’s report within the UK, the problem of AMR by 
2050 is estimated to put in risk 10 million human lives per 
year and will have spent a cumulative amount of 100 trillion 
USD [7]. Therefore, early detection of these microorganisms 
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in humans or animals is essential to provide efficient and 
adequate treatment.
Currently employed diagnostics techniques are: micros-
copy, microbial culture, ELISA, PCR, RT-PCR, multiple-
tube fermentation (MTF), SERS, and others. Microscopy 
is a very convenient technique to assess morphological fea-
tures, but is less sensitive than microbial culture, which is 
particularly time-consuming, often more than 24 h. Besides, 
microbial culture has low sensitivity and is relatively expen-
sive [8]. Some immunoassay methods such as ELISA can 
specifically detect epitopes on bacterial surfaces. However, 
diagnostics based on ELISA are time-consuming, expensive, 
have a complex and narrow detection range and often show 
cross-reactivity [9]. PCR is appropriate for tiny samples and 
results in highly specific detection. However, PCR lacks reli-
ability due to frequent false positive outcomes [10]. MTF 
consists of filtering a water sample, concentrating the bacte-
rial cells and incubating them for later detection and quan-
tification. Since the technique depends on bacterial growth, 
one test can last up to 96 h [11]. Finally, the SERS technique 
requires expensive and sophisticated laser equipment [12].
To overcome the preceding methodological difficulties, 
new technologies such as biosensing have emerged in the 
last few decades. This technology can detect and quantify 
biological analytes and combine high sensitivity and speci-
ficity with fast response times, portability, low-cost, and 
ease-of-use.
Biosensors
A biosensor [13] is defined as a compact analytical device 
that detects and quantifies a target analyte and consists of 
three elements: a biological receptor (DNA, antibodies, 
enzymes, cells) which specifically detect the target mol-
ecule; a transducer, which interprets the biological recogni-
tion event and translates it into a quantifiable signal; and a 
signal processing display. The rise of biosensors is due to 
the limitations that current techniques present such as high 
costs, requirement for qualified personnel and long response 
time. All of these complications are incompatible with early-
stage rapid diagnosis (Fig. 1).
The first biosensor [14] dates back to 1962. An electro-
chemical biosensor was developed to measure glucose lev-
els in blood. The enzyme glucose oxidase (GOx) catalyses 
the oxidation of the glucose, and the biosensor monitored 
its consumption through the change in the current at the 
working electrode. Since then, electrochemical biosensors 
have drawn the attention of several research areas due to 
their easy manipulation, great sensitivity and possibility for 
miniaturisation.
Biosensors for medical application are designed to 
detect and quantify biomedical analytes. Pathogens found 
in different bio-fluids such as saliva, urine and blood can be 
detected [15, 16]. Nowadays, implantable biosensors have 
been already developed and are in use in some patients, for 
instance for a constant monitoring of glucose [17].
Biosensors can be classified either by their bioreceptor 
element or by the transduction mechanism. Where antibod-
ies are used as bioreceptors they are called immunosensors. 
Antibodies are one of the most important bioreceptors to 
target specific analytes, taking advantage of the highly spe-
cific non-covalent interaction between antibodies and anti-
gen [18]. Classifying by the type of transducer, the main 
categories are: optical, mechanical and electrochemical [19]. 
This last category, electrochemical, can be subdivided in to 
amperometric, potentiometric, conductometric and impedi-
metric [20].
Optical biosensors
Optical biosensors are based on the measurement of absorb-
ance, reflectance, or fluorescence emission in the UV, vis-
ible, or near-infrared (NIR) [21]. The advantages of optical 
biosensors are mainly due to their high sensitivity, ability to 
monitor in real-time and the possibility of being label-free. 
The most utilized label-free transduction method is surface 
plasmon resonance (SPR).
SPR is a charge-density oscillation that occurs in the 
interface of the metal and the dielectric. In SPR, a plasmon 
wave is measured over a metal surface, and works by apply-
ing a light through the biological sample, causing a change 
in the refractive index, which is used to monitor the binding 
[22]. The commercialization of SPR is already well estab-
lished. However, optical method can also suffer the disad-
vantage of interference by coloured analytes and many bio-
fluids, for instance blood and urine, which show significant 
colour. Besides, SPR as well as many other optical methods 
requires sophisticated and expensive machinery [23, 24].
Mechanical biosensors
Mechanical biosensors detect changes in the properties 
of the surface upon a biological binding event. The sen-
sor records surface stress or oscillation frequency due to 
mass deposition. Different type of mechanical biosensors 
are: surface-stress mechanical biosensors, that measures the 
change in deflection of the cantilever when a biomolecule 
binds to the surface. A laser beam is used to obtain the posi-
tion of cantilever deflection; dynamic-mode mechanical bio-
sensors, in which the device oscillates at a fixed resonance 
frequency, that changes upon biomolecule binding. Other 
types of biosensors are quartz crystal microbalance (QCM) 
and whispering-gallery microgravity (WGM). Although 
these techniques are robust, as they monitor surface mass 
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they are less sensitive to small molecules and non-specific 
deposition can be an issue [25].
Electrochemical biosensors
Electrochemistry is the branch of the chemistry that interre-
lates electrical and chemical reactivity [26]. Electrochemical 
transduction is one of the most abundant modes nowadays 
due to its rapid response time, user-friendly application, low-
cost production and the possibility of miniaturizing the sys-
tem. The basis of an electrochemical biosensor is to measure 
the changes that take place in the proximity of the electrode 
surface. There, electrons flow between the electrode surface 
and electrolytes in solution. The changes at the electrode 
surface are monitored through parameters such as electrolyte 
resistance, charge transfer at the electrode surface or mass 
transfer from the bulk solution to the electrode surface. For 
electrochemical biosensors, transduction can be subdivided 
in the following: potentiometric, amperometric and impedi-
metric [27].
Potentiometric sensors
Potentiometric biosensors [28] measures the potential at the 
working electrode, at zero current, with respect to the reference 
electrode. This measurement takes place under equilibrium 
conditions, when no current is flowing through the electro-
chemical cell. This technique is used to assess ion concentra-
tions across the electrode surface. These biosensors combine 
biorecognition elements, mainly enzymes, with a transducer 
that measures the uptake or release of ions that occurs dur-
ing the enzyme’s action on its target. Ions such as  Na+,  K+, 
Fig. 1  Schematics of biosensor 
platforms: general overview of 
biosensors in which differ-
ent types of biorecognition 
elements and transduction 
mechanisms are shown and a 
signal processor.  Some vectors 
are reproduced from CSIRO 
ScienceImage
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 Ca2+,  H+ or  NH4+ can all be measured, but typically are  H+ 
or  NH4+. Many potentiometric sensors are essentially modi-
fied pH electrodes [29]. The relationship between the free ion 
concentration and the potential is established by the Nernst 
equation (Eq. 1) and of course the stoichiometry between ion 
and target substrate enables calibration.
where Ecell is the cell potential, E0cell is the standard cell 
potential, R is the universal gas constant, T the temperature, 
n is the charge number of electrode reaction, F is the Faraday 
constant and Q is the ratio of ion concentrations between the 
anode and the cathode.
In the case of voltammetric biosensors, the current is moni-
tored as a result of the application of a varied potential. The 
three most known voltammetry techniques are potential step, 
linear sweep, and cyclic voltammetry (CV). CV is also useful 
in biosensor fabrication at the step of polymer-layer deposition, 
known as electropolymerisation [28, 30].
Amperometric
Typically, an amperometric biosensor measures the current at 
a constant potential [31]. The first practical biosensor was the 
glucose biosensor, which measured the depletion of oxygen 
and the change in current by the enzyme catalysed reaction 
of glucose oxidase (GOx) (Eq. 2) [14]. This biosensor was 
the first of what is called the first generation glucose biosen-
sors, which are characterized for the employment of oxygen 
as a cosubstrate and the generation and detection of hydrogen 
peroxide (Eq. 3). The first generation was quickly superseded 
by replacing the need for oxygen by an electron mediator, such 
as ferrocene or potassium ferricyanide, which acts to reoxi-
dise the lavin cofactor, leading to the second generation of 
glucose biosensors. Subsequently, the reduced mediator is 
oxidized at the electrode surface such in Eqs. 4, (5) and (6) 
[32]. Later improvements consisted of developing biosensors 
in which the electron transfer was carried out without the use 
of electron mediators. Instead, there was a direct exchange 
of electrons between the enzyme and the electrode. This is 
called third generation glucose biosensors. However, recent 
improvements and continuous glucose monitoring are being 
achieved by non-enzymatic glucose biosensors. These biosen-
sors are considered the fourth generation glucose biosensors 
and are characterized for using a catalytic electrode for glucose 
oxidation. These electrodes are modified by electrodeposition, 
etching or electrochemical anodization [33].







⟷ Gluconic acid + Hydrogen peroxide
(3)H2O2 → O2 + 2H
+ + 2e−
Generally, in amperometric biosensors label-free is 
practically not possible and often an oxidoreductase 
enzyme catalyses the biochemical reaction, which turns 
into a change in current across the electrode surface, pro-
portional to analyte concentration. These biosensors allow 
rapid responses and high sensitivity. However, their use 
are limited to analytes of which there are specific enzymes 
to catalyse the redox reaction. Faraday’s Law (Eq. 7) can 
determine the relationship:
where I is the current, n the number of electrons transferred 
to the electrode, F the Faraday constant, A the area of the 
electrode and J is the Flux coefficient.
Amperometric biosensors show better sensitivity than 
potentiometric biosensors. Nevertheless, these systems 
require enzymes to oxidise or reduce a specific analyte 
[34], which is a limitation on their use. Commercial 
amperometric biosensors determine the presence and con-
centration of glucose in animals and microbial cultures 
[35], lactose and other metabolites [36] and some lipids 
such as cholesterol [37].
Impedimetric
Impedance is basically the opposition to the current flow 
in an electrical circuit. The difference between common 
resistance and impedance is that resistance obeys Ohm’s 
law and occurs in direct current (DC) circuits, where there 
is no gap between the voltage applied and the current. 
Impedance, however, occurs in full alternating current 
(AC) circuits, where there is a gap in the voltage-current 
phase angle due to appearance of capacitive and inductive 
effects. In the case of impedimetric biosensors, the imped-
ance consists of a resistive and a capacitive part as a result 
of a complex interaction with a small amplitude voltage 
signal as a function of frequency [38, 39].
Unlike amperometric and potentiometric systems, 
impedance biosensors are label free and do not depend 
on any specific enzyme for the analyte detection. Instead, 
impedimetric biosensors rely on a unique bioreceptor 
which specifically binds to the analyte such as DNA [40], 
antibodies [41, 42] aptamers [43] and various synthetic 
affinity proteins such as Affimers [5, 44].
(4)Glucose + GOx(ox) → Gluconic acid + GOx(red)
(5)GOx(red) + 2M(ox) → GOx(ox) + 2M(red) + 2H
+
(6)2M(red) → 2M(ox) + 2e
−
(7)I = n ⋅ F ⋅ A ⋅ J,
347Medical Microbiology and Immunology (2020) 209:343–362 
1 3
Brief description of electrochemical 
impedance spectroscopy (EIS)
Electrochemistry at electrode surface
When EIS is used on a biosensor, several parameters are 
obtained. Bulk impedance (Z) can be separated into real and 
imaginary component, which are the resistive (Z′) and the 
capacitive (−Z″) parts, respectively (Fig. 2). The resistive 
part is originated by the electrode surface through the oppo-
sition to the current flow. The capacitive part measures the 
storage of charge of the system when a voltage is applied. 
At the electrode-solution interface, there are two ways in 
which electricity can flow through the electrode: when the 
electrons are transferred to the electrodes by means of redox 
reactions it is called a Faradaic process and behaves accord-
ing to Faraday’s law. When no charge is transferred to the 
electrode surface, however, electricity can flow through 
since the system behave as a capacitor, it is called a non-
Faradaic process [45, 46].
The basis of EIS consists of applying a low amplitude 
voltage sine wave to an electrochemical system over a range 
of frequencies. As a result, the current and its phase angle 
is obtained. The impedance is the ratio between the applied 
voltage and the current (Eq. 8) and indicates the opposi-
tion of an electrical circuit to the flow of electrons in the 
AC circuit. Impedance-based biosensors culminate with a 
bioreceptor-analyte interaction which causes modifications 
to the electrical field due to a change in the capacitance and 
electron transfer resistance at the working electrode surface 
[39].
where Z is the impedance, V is the voltage, I is the current, j 
is the imaginary component and ω is the frequency.
When the phase angle between the voltage and intensity is 
equal to zero, as in a pure metal surface, the impedance and 
resistance become the same. Nevertheless, in the majority 
of real electrical circuits the angle is different from zero as a 
consequence of capacitive and/or inductive effects.
To assess the impedance of an electrochemical system in 
Faradaic biosensors, the modified surface of the biosensor 
electrode is immersed in a solution containing an electron 
mediator. The most commonly used redox pairs include 
[Fe(CN6)]3−/4− (ferricyanide/ferrocyanide), [Ru(NH3)6]3+/2+ 
hexaammineruthenium (II/III) and ferrocene  (Fc+/Fc). In 
non-Faradaic circuits, impedance is measured without a 
redox mediator [13].
Usually, a SAM or a polymer layer are used to cover 
the electrode surface. This coating provides a surface to 
immobilize the bioreceptors, increases their bio-stability 
and creates a dielectric between the surface and the media. 
Self-assembled monolayers (SAMs) require a molecularly 
flat surface, incompatible with the roughness presented by 





Fig. 2  Phasor diagram: a phasor 
diagram shows the change in 
phase angle (θ) and magnitude 
(|Z|) when analyte binding 
occurs
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conducting and non-conducting polymers are typically elec-
trodeposited onto metal surfaces. These polymers are good 
base layers since they can be electrodeposited onto rough 
surfaces and the thickness of the polymer itself can be con-
trolled. Conducting polymers such as polyaniline (PANI) 
or polypyrrole (PPy) exhibit conductive or semi-conductive 
properties whereas non-conducting polymers like polyt-
yramine (Ptyr) offer high resistivity and contribute to highly 
sensitive detection [46, 47].
Equivalent circuit and data presentation
Common formats for impedance data presentation are the 
Nyquist and Bode plots. In the Nyquist plot (Fig. 3a), the 
imaginary part of impedance (−Z″), out of phase, is plotted 
against the real component (Z′), in phase, at each excitation 
frequency whereas the Bode plot, shows the logarithm of 
absolute impedance and phase shift (Θ) versus the log of 
excitation frequency. The Nyquist plots shows the relation-
ship between real and imaginary components of impedance 
for a range of frequencies and are typically used to assess 
the resistive component of the system whereas Bode plots 
are used to study mainly the capacitive [48, 49]. The Nyquist 
plot is explained in detail for the common use of data assess-
ment in this project (Fig. 3a).
The behaviour of the system is different at high and low 
frequencies. At high frequencies, the signal is controlled by 
kinetic processes: electron mediator molecules change in 
charge direction before the redox reaction at the electrode 
surface takes place. This fact constitutes a limiting factor 
since it delays the charge transfer across the electrode. This 
limitation is known as solution resistance (Rs). At medium 
frequencies, there is barely resistance in the system. As a 
consequence, the changes originated in the system are due to 
capacitance, specifically from the double layer capacitance 
(Cdl) at the electrode surface. At low frequencies, charge 
Fig. 3  General scheme of a Nyquist plot and its Randles’ equivalent 
circuit: a Nyquist plot emerges from plotting the imaginary (capaci-
tive) against real (resistive) components of impedance. Most relevant 
features are: resistance of the solution Rs; charge transfer resistance 
Rct; the maximum double-layer capacitance Cdl and the Warburg 
impedance W, which is only observed in Faradaic sensors and rep-
resents mass transfer diffusion effects. b Randles’ equivalent circuit 
representing an electrical circuit modelling a Faradaic sensor
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transfer is only produced by the resistance offered from the 
biosensor construct, since the opposition found by the elec-
tron mediators is due to the surface components. This resist-
ance is calculated through the charge transfer resistance (Rct) 
[50]. In some occasions, at low frequencies, is seen Warburg 
impedance (W), which is manifested as a linear tail at the end 
of the Nyquist arc. This phenomena occurs due to diffusional 
limitations of the systems, when it runs out of charge carri-
ers [46]. The equivalent circuit for all these components is 
represented on a Randles’ equivalent circuit (Fig. 3b) which 
models the behaviour of a typical Faradaic biosensor.
Generally, the tendency of the impedance value is to 
increase as the complexity of the functionalized electrode 
increases: electrons in solution face more obstacles when 
reaching the electrode surface and thus, more resistance is 
observed (Fig. 4). However, a decrease in impedance can 
occur upon analyte binding, since analyte binding can dis-
tort the polymer layer and make electron mediator access 
easier [51].
In Faradaic measurements, the main aim is to calcu-
late the charge transfer resistance and the current flowing 
through the biosensor surface. In contrast, in non-Faradaic 
measurements, a voltage at low frequencies is applied and 
the current flows through the biosensor after accumulat-
ing the capacitive components of the surface. In general 
terms, Nyquist plots are typically used for resistive systems 
whereas Bode plots are used for capacitive [48, 49].
In this review the progress of impedimetric immunosen-
sors field in the last two decades is discussed, according to a 
wide range of pathogens and biomarkers. The characteristics 
of a biosensor are the working electrode, target element, 
immobilization step, limit of detection (LOD), detection 
time and sample volume. Previous reviews about biosen-
sors classify them either by type of bioreceptor or by type 
of transducer. In this case, the bioreceptor consists of an 
antibody and the transducer component is an impedance 
electrode. Thus, the classification in this review is organised 
by type of analyte: bacteria, virus and fungi, biomarkers and 
a final section of new protein receptors.
Immunosensors for pathogen detection
Escherichia coli (E. coli)
Escherichia coli is a gram-negative bacteria primarily found 
in the intestines of mammal and birds. Common strains are 
not harmful even at high concentrations. However, a few E. 
coli strains can cause illness, for instance strain O157:H7 
which produces a haemorrhagic toxin and causes haemor-
rhagic colitis [52]. Impedimetric immunosensor platforms 
for E. coli have been the object of many studies due to its 
easy manipulation in the laboratory and it being a surrogate 
organism for sensing faecal pollution of water [53].
One of the first relevant cases of an E. coli impedance 
immunosensor [54] employed gold interdigitated array 
microelectrodes (IDAMs) and were modified and inserted 
in a microfluidic device [55] for E. coli O157:H7 detec-
tion. The system was capable of detecting concentrations 
as low as 1.2 × 103 CFU/mL from ground beef samples and 
1.6 × 102 CFU/mL from pure culture in only 35 min using 
100 µL of sample. Specific antibodies against E. coli were 
conjugated to magnetic nanoparticles via biotin-strepta-
vidin coupling, forming magnetic nanoparticle-antibody 
Fig. 4  General scheme of impedance for each step of biosensor con-
struction. Impedance increases as the deposition over the surface 
electrode increases. Deposition of material onto biosensor surface 
normally causes an increase in both resistance and capacitance, which 
impedes the transfer of electrons between the solution-based media-
tors and the electrode surface. Therefore, impedance increases from 
(a), bare electrode when (b), bioreceptors are immobilized and (c), 
increases upon analyte binding
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conjugates (MNAC). These conjugates captured bacteria and 
concentrated them after applying a magnetic field. Eventu-
ally, the sample was placed into the microfluidic device for 
impedimetric assessment. Unlike macro-sized electrodes, 
which generally consists of a metal bar immersed into a 
solution, the use of IDAMs in impedance immunosensors 
[56] presents several advantages. For instance, lower detec-
tion limit, higher signal/noise ratio, shorter detection time 
and lower sample volume. The IDAMs’ design is based on 
a pair of parallel microband array electrodes that mesh into 
each other forming a set of interdigitated electrode fingers. 
Frequently dimensions used for IDAMs are 0.1–0.2 µm 
high for each electrode finger, 1–20 mm in length with an 
inter-electrode space of 1–20 µm. Gold is the most prevalent 
material for IDAM fabrication. However, the use of indium 
tin oxide (ITO), Pt, Ti, Pd or Rh is also mentioned [20, 55].
Escherichia coli O157:H7 detection in river water [57] 
was achieved by covering gold electrodes with a mercap-
toacetic acid (MACA) SAM. Subsequently, the construct 
was treated with N-ethyl-N-(dimethylaminopropyl)-carbod-
iimide (EDC) and N-hydroxysuccinimide (NHS) to catalyse 
the creation of a peptide bond with antibodies. The co-addi-
tion of NHS and EDC causes the replacement of the termi-
nal carboxylic group of MACA by an NHS ester which is 
then subjected to nucleophilic attack by an amine group. An 
LOD of 1 × 103 CFU/mL analysing a small sample volume 
of 20 µL was achieved in 1 h, which compared to 100 µL 
sample [54] decreases the volume despite longer detection 
time but was still acceptable. Usually, SAMs forms an insu-
lation barrier between the electrode and the analyte solution, 
thus behaving as a dielectric. This dielectric barrier is used 
to investigate electron transfer [58].
A microfluidic biosensor platform was describe for E. 
coli and Staphylococcus aureus (S. aureus) detection [59]. 
On this occasion, antibodies were attached onto a modi-
fied alumina nanoporous membrane with self-assembled 
(3-glycidoxypropyl) trimethoxysilane (GPMS) SAM. The 
use of nanoporous alumina membrane in impedimetric 
immunosensing is due to the increase in the electron transfer 
through the electrode-solution interface caused by its high 
pore density, successful biocompatibility and expansion of 
surface area. Moreover, these membranes are extraordinar-
ily long-lasting and the pore size can be regulated without 
difficulty [60]. Both type of bacteria were detected in 2 h 
and at an LOD of  102 CFU/mL was achieved. Alumina 
nanoporous membrane was also reported [61] but adding 
a modification with hyaluronic acid (HA) (Fig. 5). HA is 
a hydrophilic non-sulphated glycosaminoglycan which is 
used in immunosensor construction to improve the signal/
noise ratio by decreasing non-specific background signals. 
It also enhances antibody immobilization due to its carboxyl 
groups. The biosensor platform could detect concentra-
tions of E. coli as low as 83.7 CFU/mL in milk samples. 
Therefore, the introduction of HA improved the previous 
sensitivity obtained in [59]. In other cases of biosensor fab-
rication using HA [2], introducing a conducting polyaniline 
(PANI) film surface prior to antibody immobilization [62] 
led to a low LOD of 2 CFU/mL [27] being reported.
Reduced graphene oxide paper (rGOP) electrode modi-
fied with gold nanoparticles (AuNPs) was used as a novel 
system for E. coli O157:H7 detection in cucumber and 
ground beef samples [53]. The AuNPs were electrodepos-
ited onto the graphene paper and antibodies were linked to 
them via biotin-streptavidin coupling. Graphene, in addition 
to its advantages of biocompatibility, rapid electron transfer 
and large specific area surface, is characterised for its high 
flexibility and thus their great importance in impedimetric 
immunosensors. Incorporation of AuNPs in the biosensors 
construction was carried out due to their well-known func-
tionalization chemistry and electrochemical properties [63]. 
AuNPs create an appropriate microenvironment for the sta-
bilization and immobilization of biomolecules as well as 
ease the electron transfer between the bulk material on the 
electrode and the electrode itself [64]. Some impedimetric 
immunosensors require an amplification step in order to 
increase sensitivity, for instance by employing AuNPs [65] 
or the lectin wheat germ agglutinin (WGA) (Fig. 6). In this 
case, screen-printed interdigitated microelectrodes (SPIMs) 
was used as a biosensor platform, covered with 3-dithiobis-
(sulfosuccinimidyl propionate) (DTSP), and further func-
tionalized until depositing antibodies. Once the bacteria was 
tested, WGA served as a signal amplifier [66]. The biosensor 
functionalization can be followed in (Fig. 6a) scheme and 
each step monitored through impedance and show in Nyquist 
plot in (Fig. 6b). Different bacterial concentrations are plot-
ted by % change in impedance in (Fig. 6c).
Magnetic nanobeads served as a substrate to be coated 
with antibodies [67]. These antibody-coated magnetic nano-
beads are used for separating and transporting the bacteria 
from the initial culture into another platform for electro-
chemical measurement and for concentrating and precipi-
tating the pathogen onto the electrode by placing a magnet 
under the electrode. Common materials for working elec-
trodes are gold, silver, platinum and carbon. However, a 
biosensor platform was built over an (ITO) electrode [68] 
and showed successful results: an LOD of 1 CFU/mL in a 
400 µL PBS sample could be obtained in 45 min. Similarly, 
a gold-tungsten microwire was used as a working electrode 
modified with polyethyleneimine (PEI) SAM for E. coli K12 
detection [69]. One of the latest impedimetric immunosensor 
fabrication [3] tried 5 distinct manners of functionalizing 
the electrode surface with anti-E. coli onto a gold SPE and 
detected an LOD of 3 CFU/mL in 90 min for a 1 mL sample. 
Considering main important features such as LOD, detection 
time and sample volume, the biosensors using ITO electrode 
[68] and gold SPE [3] provide better sensitivity whereas 
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the biosensors using gold IDAM [54] and gold electrode 
with a MAA SAM [57] use considerably smaller sample 
volumes, thus less invasive towards the obtaining sample 
from patients. All four detection could be carried out in a 
relative short detection time, from 35 to 90 min.
Salmonella
Salmonella is a gram-negative bacteria which belongs to 
the Enterobacteriaceae family. The most prevalent types 
of Salmonella which infect humans are Salmonella typh-
imurium (S. typhimurium) and Salmonella typhi (S. typhi). 
S. typhimurium is the less virulent and its common symp-
toms appear 12–72 h after infection. They include fever, 
diarrhoea, abdominal colic and headache. However, S. tiphi 
causes typhoid fever disease, causing around 200,000 deaths 
per year and a morbidity of approximately 20 million new 
cases per year [70].
An immunosensor for S. typhimurium evaluation in milk 
samples [71] was fabricated using a gold working elec-
trode covered with a thiol-based SAM in which antibodies 
against Salmonella were attached via glutaraldehyde cross-
linking. The immunosensor platform could attain an LOD 
of  102 CFU/mL in a 2 mL PBS after 2 h whereas an LOD of 
 102 CFU/mL was obtained after 10 h in a 2 mL milk sample. 
Similarly, antibodies were also attached to the SAM via glu-
taraldehyde [72]. One thousand  (103) CFU/mL in 1 mL of 
pathogen could be detected in only 20 min, thus improving 
Fig. 5  a Scheme of the 
impedimetric immunosensor 
constructed into a HA-coated 
alumina nanoporous for E. 
coli detection inserted into a 
microfluidic device. b A FE-
SEM image showing bacteria 
captured over the nanoporous 
membrane. Scale bar is 1 μm. 
c the plot on the left shows a 
normalized impedance change 
(NIC) for different bacteria 
concentration and the plot on 
the right shows the validation 
experiments through negative 
control bacteria.  Reprinted 
from [61], with permission from 
Elsevier
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results published in [71]. Gold IDAMs were employed for 
immunosensor construction [73] using novel magnetic silica 
nanotubes (MSNTs) to capture bacteria through electrostatic 
interaction. The use of MSNTs is due to their multifunc-
tional structure and for being less susceptible to self-aggre-
gation under elevated levels of salt in the media. Another 
cases using a gold IDAM [74] was able to detect in 1 h an 
LOD of  102 CFU/mL in only 50 µL volume, thus improving 
previous sample volumes reported in [71, 72]. For S. typhi 
detection [75] AuNPs were coated with antibodies and an 
LOD of  102 CFU/mL in 10 µL sample could be achieved 
in 1 h.
Sulphate reducing bacteria (SRB)
The electron transport chain of Desulforibrio caledoiensis, 
an SRB, possesses a sulphate as a terminal electron accep-
tor and thus, produces sulphide, which is known for being 
a major problem for industries and the environment. One 
of the first impedimetric immunosensor for SRB detection 
immobilized the lectin-concanavalin A (ConA) for an agglu-
tination assay [76]. The gold electrode was modified with a 
SAM onto which the lectin ConA was immobilized. Each 
lectin molecule presents four carbohydrate-combining sites. 
Therefore, when lectins react with cells they will also cause 
cross-linking and then precipitation [77]. A immunosensor 
for SRB [78] introduced the utilization of a Ni foam, covered 
with 11-mercaptoundecanoic acid (MPA), which worked as 
a platform for trapping bacteria. This system is depicted in 
Fig. 7. Further inclusion of reduced graphene sheets (RGS) 
in the SRB biosensor [79] was also reported. These 2D nano-
structures are biocompatible, provide a redox catalyst and a 
low manufacturing cost [80]. A RGS-doped chitosan nano-
composite film biosensor platform could detect a range of 
bacteria at concentrations from 1.8 × 102 to 1.8 × 107 CFU/
mL. In comparison to the work on SRB detection [76, 78], 
Fig. 6  a Scheme for layer-by-layer construction of the impedimetric 
detection immunosensor. b Nyquist plot of each step electrode func-
tionalization. For bare electrode the impedance value is almost negli-
gible. As the complexity of the electrode surface increases the imped-
ance also does since the pathway of the electrons to get the surface 
is more hindered. c Impedance change (%) plotted against log (CFU/
mL) of bacteria concentration. The increase in bacteria concentration 
creates a thicker platform, which turns an increase in the impedance 
value.  Reproduced from [66]
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this RGS-based immunosensor obtained faster results and, 
even though the sensitivity was not improved, the sample 
amount could be as low as 10 µL.
Listeria monocytogenes
Listeria monocytogenes is a gram-positive bacteria whose 
infection takes place via contaminated food ingestion. Gen-
erally, the diseases caused by this bacteria includes febrile 
gastroenteritis, perinatal infection and systemic infections in 
which the central nervous system is affected. Hence, faster 
and cheaper methodologies such as impedimetric immu-
nosensor have been researched [81].
An immunosensor [82] for Listeria monocytogenes 
employed a  TiO2 nanowire bundle microelectrode. Patho-
gen detection was accomplished in 50 min for an LOD of 
4.7 × 102 CFU/mL in 15 μL sample. This clearly outper-
formed the common immunoassay detection and dot blot 
assay, with LODs of  104 CFU/mL and 2.2 × 105 CFU/mL 
respectively. The use of a  TiO2 nanowire is mainly due to 
its unique semi-conductive band gap not found in other 
nanowires, favourable biocompatibility and good chemi-
cal and photochemical stability, as well as easy fabrication 
[82]. Forward steps towards miniaturisation and low vol-
ume samples were also achieved [83] by inserting a bio-
sensor into a micro fluidic device. Magnetic nanoparticles 
30 nm diameter were coated with antibodies against the 
pathogenic bacteria via biotin-streptavidin coupling. The 
system could analyse bacteria in a 3-h immunoreaction for 
food samples (milk, ground beef and lettuce), achieving 
an LOD of  104 CFU/mL. Due to microfluidic chip use, the 
volume sample required was only 20 nL, which justifies 
the limitation of sensitivity when using minimal sample 
volume. The main features of using a microfluidic device 
for biosensing include an increased ratio surface/volume 
and the insertion of small volumes in the order of nanolit-
ers inside the microchannels, turning into a considerable 
reduction of the detection time and minimising the cost of 
reagents [83].
Fig. 7  a General scheme of the biosensor construction for SRB detection over 3D-foam Ni foam. b Change in Rct plot showing a calibration 
curve for different bacterial concentrations.  Reprinted from [78], with permission from Elsevier
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Pseudomonas aeruginosa, Streptococcus pyogenes 
and Staphylococcus aureus
Pseudomonas aeruginosa is a gram-negative bacteria com-
monly found in contaminated water. Infections by this path-
ogen in humans is manifested as urinary tract infections, 
respiratory system infections and systemic infections among 
others. An impedimetric immunosensor for this pathogen 
[84] was designed by immobilising polyclonal antibodies 
against P. aeruginosa over a screen-printed carbon elec-
trode (SPCE). Streptococcus pyogenes is a gram-positive 
bacterium responsible of pharyngitis, scarlet fever (rash) 
impetigo, cellulitis, or erysipelas. An immunosensor was 
described [41] in which Dropsens gold SPEs were modified 
by depositing a polytyramine (Ptyr) layer. Subsequently bio-
tin tagged antibodies were attached via biotin-NeutrAvidin. 
An LOD of  102 cells were achieved for single shot incuba-
tion method with a sample volume of 10 µL in only 30 min 
(Fig. 8). S. aureus is a gram-positive bacteria member of 
the Micrococcaceae family. Infections caused by this patho-
gen include diseases such as pneumonia, heart valve infec-
tions and bone infections which produces a considerable 
morbidity and mortality. An impedimetric immunosensor 
for stressed and resuscitated S. aureus assessment [85] was 
developed by modifying a gold electrode with an insulat-
ing 6-mercaptohexadecanoid acid SAM in which specific 
antibodies against S. aureus were attached for the further 
immunoreaction.
Viral and fungal detection
Avian Virus Influenza (IV) H5N1 is highly pathogenic 
and mainly occurs in birds. However, human infection by 
this virus is generally associated with several disease and 
death. A biosensor platform for IV H5N1 detection [86] 
immobilized polyclonal antibodies against IV H5N1 surface 
antigen HA (hemagglutinin) over a modified gold IDAM via 
protein A. An LOD of  103  EID50/mL  (EID50: 50% egg Infec-
tive Dose) and linear detection range from  103 to  107 CFU/
mL was achieved in 2 h in a 50 µL sample. Protein A adsorbs 
easily onto the gold IDAM surface through electrostatic and 
hydrophobic interactions. Besides, this protein shows high 
affinity to the anti-H5N1 IgG Fc region, which facilitates 
antibody immobilization onto the electrode surface. Simi-
larly, IV H5N1 detection in chicken swabs was achieved 
[38]. A gold IDAM was used as an electrode platform and 
was functionalised via protein A with monoclonal antibodies 
against IV H5N1. Concentrations from  2–1 to  24 HAU/50 µL 
(HAU: hemagglutination units) could be assessed in a 30 µL 
sample after 45 min.
Other impedimetric immunosensors include a regener-
able biosensor for adenovirus type 5 (Ad5) detection [87], a 
biosensor for plum pox virus (PPV) [88] which affects plants 
from genus Prunus and a biosensor platform for the patho-
gen oomycete fungus Aphanomyces invadans [89], known 
to cause epizootic ulcerative syndrome (EUS).
Biomarker detection
Biomarkers for cardiovascular disease (CVD)
Cardiovascular diseases (CVD) is a major cause of death 
worldwide, estimated to be up to 30%. Several disorders 
such as deep vein thrombosis (DVT), congenital heart dis-
ease, pulmonary embolism, cerebrovascular disease, coro-
nary heart disease, rheumatic heart disease and peripheral 
artery disease are include in CVD. Some unmodifiable risk 
factors of suffering from a CVD are the gender, age, eth-
nicity and family history whereas among modifiable risk 
factors can be found in tobacco use, sedentary lifestyle, 
Fig. 8  On the left, there is the 
general scheme of immunosen-
sor against Streptococcus 
pyogenes construction layer-by 
layer over a DropSens gold 
SPE (CX2223AT). On the top 
right, a fluorescence imaging of 
bound S. pyogenes on the sensor 
surface. On the bottom right, 
there is a % change in imped-
ance plot upon the addition of 
different bacteria concentra-
tion, from  104 to  108 cells/mL.  
Reproduced from [41], with 
permission of ACS
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hypertension, obesity, hyperlipidemia and stress. According 
to epidemiological studies, preventive measures are the best 
treatment for CVD [90]. This fact leads to monitor different 
biomarkers related with CVD for early diagnostics.
Myocardial infarction (AMI) requires of a rapid and accu-
rate diagnostic. Myoglobin (Mb), cardiac troponins (cTn), 
creatine kinase MB (CK-MB) and myeloperoxidase (MPO) 
are indicators of elevated risk of AMI. In 2010, an impedi-
metric immunosensor for Mb was constructed over a flat 
gold wire (Fig. 9). Myoglobin, which consists of a 17.8 kDa 
protein, was detected in aqueous solution over linear range 
from 10 to 650 ng/mL, with an LOD of 5.2 ng/mL [91]. Fur-
ther impedimetric immunosensors for Mb have been devel-
oped. An impedimetric immunosensor for Mb was achieved 
by [92], reaching an LOD of 1.70 ng/mL and could detect 
a linear range from 0.01 to 1 μg/mL in less than 15 min for 
samples in PBS. Several novel components were included 
in the biosensor architecture. An indium-tin-oxide (ITO) 
glass plate was employed as electrode platform, in which 
a SAM was deposited and then functionalized with plati-
num nanoparticles prior to antibody attachment. However, 
the most sensitive impedimetric immunosensor for Mb was 
achieved by [93], in which Screen-printed multi-walled car-
bon nanotubes electrodes (MWCNTs) [94] could improve 
the sensitivity of Mb detection. An LOD of 0.08 ng/mL 
could be achieved and a linear range from 0.1 ng/mL to 
90 ng/mL could be detected in 5 µL samples. Several novel 
components were included in the biosensor architecture. An 
indium-tin-oxide (ITO) glass plate was employed as elec-
trode platform, in which a SAM was deposited and then 
Fig. 9  a Scheme of the biosen-
sor construction for Mb detec-
tion. A flat gold wire is used as 
electrode to be functionalized 
with anti-Mb, blocked with 
BSA, and finally tested with 
Mb; b shows the impedance 
values for each step of the 
biosensor construction; and c 
the impedance values shown 
through a Nyquist plot for 
increasing concentration of the 
analyte.  Reprinted from [91], 
with permission from Elsevier
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functionalized with platinum nanoparticles prior to antibody 
attachment. Other CVD biomarkers have also been detected 
though impedimetric biosensing. Cardiac troponin I (cTnI), 
which is used as a definitive biomarker for AMI diagnosis 
and soluble lectin-like oxidized LDL receptor-1 (sLOX-1), 
which serves as a biomarker for early diagnostic of AMI 
and acute coronary syndrome (ACS), were detected in PBS 
and in serum samples. The sensitivity of the final sensor 
could detect an LOD of  10–13 M for each analyte [95]. A 
more recent investigation, lead to a better biosensor platform 
for cTnI detection. An LOD of 11.7 fM was achieved and 
a linear range from 42 fM to 42 nM could be detected in 
approximately 1 h [96]. The biosensor construction included 
the addition of dendrimer before antibody attachment, which 
improved the LOD over 120 times. The reliability of the 
biosensor prototype was checked in parallel with ELISA, 
and resulted in a robust method for cTnI detection in serum. 
Biosensors have also reached other diseases such as deep 
vein thrombosis (DVT), which is typically indicated by the 
appearance of D-dimer. A platform based on a gold micro-
electrode was functionalized with single-walled carbon 
nanotubes (SWCN) and anti-D-dimer in order to detect the 
mentioned molecules at levels of 0.1 pg/mL (53 fM) in less 
than 10 min [97].
Biomarkers for cancer
Several types of cancer such as ovarian, breast and pancre-
atic cancer can be early detected by assessing the levels of 
the protein human epidermal growth factor receptor (EGFR). 
A disposable CNT based biosensor was developed and could 
detect EGFR at low levels such as 2 fg/mL, improving the 
LOD of 4 pg/mL provided by commercial kits by then [98]. 
Another biosensor for EFGR detection was developed by 
depositing AuNPs and LODs of 0.34 pg/mL and 0.88 pg/
mL were achieved for samples in PBS and in human plasma 
respectively [99]. Clinical observational methods have dem-
onstrated that 1 out of 3 men over 50 years old have evi-
dence of histologic prostate cancer, although in a several 
number of cases the tumour is small and insignificant [100]. 
Then, it is important to develop rapid detection platforms for 
early-diagnosis. A gold microelectrode was used a platform 
to construct an impedimetric immunosensor for prostate-
specific antigen (PSA) detection and quantification, which 
is a biomarker overexpressed in prostate cancer. An LOD in 
the order of ng/mL was achieved [101].
The progression of ovarian cancer can be followed by 
monitoring the serum oncomarker cancer antigen 125 (CA-
125). For that, an impedimetric immunosensor for CA-125 
determination was developed over a gold electrode platform 
that was previously functionalized with silica coated gold 
nanoparticles and quantum dots [102, 103]. The system 
could detect CA-125 in serum of ovarian cancer patients 
with an LOD of 0.0016 U/mL in less than 1 h [104]. Nega-
tive regulator protein murine double minute 2 (MDM2) 
serves as a tumour brain marker. A biosensor for MDM2 
was develop to detect this protein in health mice and mice 
with brain tumours. For that, a biosensing platform was built 
over a polycrystalline gold electrode. MDM2 biomarker was 
detected in PBS and brain homogenate samples, with an 
LOD of 0.29 pg/mL and 1.3 pg/mL respectively, both in less 
than 1 h, and thus improving the detection time of commer-
cial kits which last for 5 h [105]. Paediatric adrenocortical 
carcinoma (pACC) is an unusual cancer typically found in 
South America. It is characterized for the high production 
of dehydroepiandrosterone sulphate (DHEAS). This pACC 
biomarker was detected by developing a biosensor over an 
oxidised glassy carbon electrode that was functionalized 
with AuNPs. An LOD of 7.4 μg/dL in blood serum samples 
was achieved [106].
Biomarkers for bacterial and other diseases
Triggering receptor-1 expressed (TREM-1) is a biomarker 
which indicates a response to bacterial sepsis, whilst 
N-3-oxo-dodecanoyl-l-homoserine lactone (HSL) is pre-
sent in pathogenic wound infections. Therefore, the need 
for a rapid detection of these molecules can be crucial for a 
fast response towards wound infection. The construction of 
an impedimetric immunosensor for these biomarkers was 
accomplished [52]. Gold SPEs were modified with antibod-
ies and the detection was achieved in less than 1 h in a 10 µL 
mock wound samples. LODs were 3.3 pM for TREM-1 and 
1.4 nM for HSL, which are near or below the limits required 
to consider the presence of infection.
Tuberculosis is one of the most prevalent and impor-
tant worldwide diseases due to its virulence and death rate 
among the centuries. This disease is caused by Mycobac-
terium tuberculosis, which affects mammals and it is esti-
mated to cause the death of 2 million people per year. Physi-
cal examination, chest X-ray as well as bacterial cultures 
are some of the routine diagnosis procedures. A biosensor 
included into a microfluidic platform [107] detected samples 
of human and bovine tuberculosis at concentrations as low 
as 10 ng/mL in a 10 µL sample. The test lasted for 10 min 
without the need to modify the electrode surface since anti-
bodies were attached to the surface by passive adsorption. 
Other biosensors for CD14 and CD16 monocyte detection 
as indicators of infectious state were also reported [108].
Other bioreceptors
There are several proteins derived from antibodies such as 
nanobodies. Nanobodies are single-domain antibody frag-
ments found in camelids [109], which have demonstrated to 
properly work as bioreceptors. A biosensor using nanobodies 
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Table 1  A summarize of the different impedimetric immunosensors found in the literature
Immunosensor 
electrode
Analyte Immobilisation step LOD Sample volume Detection time References
Au IDAM E. coli O157:H7 MNAC/SA/BT/Ab − 1.2 × 103 cfu/mL 
from ground beef 
samples
− 1.6 × 102 cfu/mL 
from pure culture
100 μL 35 min [54]
Au E. coli O157:H7 MACA/EDC + NHS/Ab 1 × 103 cfu/mL in 
culture
20 μL 1 h [57]
Au E. coli O157:H7 MHDA/
(EDC + PFP + DIEA)/
Ab/AEE
2 cfu/mL _ 45 min [27]
Pt wire E. coli O157:H7 /
Staphylococcus 
aureus
NAM/GPMS/Ab 102 cfu/mL _ 2 h [59]
Ag/AgCl E. coli O157:H7 NAM/HA/EDC + NHS/
Ab
83.7 cfu/mL in milk _ _ [61]
Au microelectrode E. coli O157:H7 PANI/GLU/Ab 102 cfu/mL _ _ [62]
Au E. coli O157:H7 11M1UD/ECD/HA/
EDC + NHS/Ab
7 cfu/mL 1 mL _ [2]
rGOP E. coli O157:H7 Au-NPs/SA/BT/Ab/BSA − 1.5 × 103 cfu/mL 
cucumber
− 1.5 × 104 cfu/
mL ground beef 
samples
_ _ [53]
Au E. coli O157:H7 MUA/EDC + NHS/Ab/
AuNPs
102 cfu/mL _ 2 h [65]
Au SPIM E. coli O157:H7 DTSP/EDC + NHS/SA/
BT/Ab/BSA/WGA 
102 cfu/mL _ < 1 h [66]
Au SPIM E. coli O157:H7 MgNbs/SA/Biotin/Ab 1.4 × 103 cfu/mL 25 μL _ [67]
ITO E. coli O157:H7 GPMS/Ab 1 cfu/mL 400 μL 45 min [68]
Au-W microwire E. coli K12 PEI/SA/BT/Ab 103 cfu/mL 5 μL _ [68]






3 cfu/mL 1 mL 90 min [3]
Au S. typhimurium Ptyr/GLU/Ab/BSA − 10 cfu/mL in 
culture
−  102 in milk
2 mL 3 h, 10 h respec-
tively
[71]
Au SPE S. typhimurium Cys/Glu/Ab/BSA −  103 cfu/mL in 
PBS
− 9 × 103 in milk
1 mL 20 min [72]
Ti-Au IDAM S. typhimurium MUA/EDC + NHS/Ab/
BSA
103 cfu/mL _ 30 min [73]
Au IDAM S. typhimurium 16-MHDA/SA/BT/Ab 102 cfu 50 μL 1 h [74]
Pt interdigitated 
microelectrodes
S. typhi Au-NPs/AbPEG-thiol 102 cfu/mL 10 μL 1 h [75]
Au SRB MUA/EDC + NHS/
lectin-ConA
1.8 cfu/mL _ 2 h [76]
Foam Ni SRB AuNPs/11-MUA/
EDC + NHS/Ab/BSA
2.1 × 101 cfu/mL _ 2 h [78]
Glassy carbon disc SRB CS + RGS/Glu/Ab/BSA 1.8 × 101 cfu/mL 10 μL 1 h [79]
Au microelectrode L. monocytogenes TiO2 nanowire/(SH-
(CH2)3-CH3)/Ab
4.7 × 102 cfu/mL 15 μL 50 min [82]
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Table 1  (continued)
Immunosensor 
electrode
Analyte Immobilisation step LOD Sample volume Detection time References
IDAM L. monocytogenes MNPs/SA/BT/Ab 104 cfu/mL in milk, 
beef and lettuce
20 nL 3 h [83]
SPCE P. aeruginosa PP3CA/EDC + NHS/Ab 10 cfu/mL _ [84]
Au SPE S. pyogenes Ptyr/BT/NA/BT/Ab/
BSA
102 cfu/ml 10 μL 30 min [41]
Au S. aureus MHDA/EDC + NHS/Ab 10 cfu/mL 5 mL _ [85]
Au IDAM AI virus H5N1 Protein A/Ab/BSA titer higher than  103 
 EID50/mL
50 μL 2 h [86]





200 μL _ [87]
Au PPV 1,6-HDT/AuNPs/Ab/
BSA
10 pg/mL _ 30 min [88]




309 ng/mL _ 10 min [89]
Au SPE TREM-1/MMP-9/
HSL
Thiolated Ab − 3.3 pM for 
TREM-1
− 1.1 nM for 
MMP-9 from 
mock wound fluid
− 1.4 nM for HSL





lyte in PBS and 
serum
_ 30 min [112]





103 cfu/ml 1 mL 2 h [108]
Flat Au wire Mb MUA-MPA/EDC-NHS/
Ab-Mb/BSA
5.2 ng/ _ _ [91]
Screen-printed 
MWCNTs
Mb Ab-Mb/BSA 0.08 ng/mL 5 μL _ [93]













Au microelectrode D-dimer SWCN-COOH/Ab/
Casein
0.1 pg/mL (0.53fM) _ 10 min [97]
SWCNT SPE EGFR CNT/EDC/NHS/Ab/
BSA
2 fg/mL _ _ [98]
Au EGFR AuNPS/Cys/PDITC/
Proteing G/Ab
− 0.34 pg/mL in 
PBS
− 0.88 pg/mL in 
human plasma
_ 1 h [99]




− 0.51 ng/mL for 
t-PSA






0.0016 U/mL in 
serum of ovarian 
cancer patients
_ < 1 h [104]
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was constructed over a glassy carbon electrode platform, 
and determined the concentration of testosterone in over 1 h, 
achieving an LOD of 0.045 ng/mL [110]. Another case of 
nanobody-based impedimetric biosensor was constructed to 
detect rabbit IgG, whose production is very demanded for its 
frequent use in companies [111].
Affimers are a non-antibody scaffolds considered as a 
good alternative as a binding protein [44]. An impedimetric 
biosensor based on Affimer binding bioreceptor was used 
to detect and quantify Her4 protein tumour, getting an LOD 
lower than 1 pM in less than 30 min of sample incubation 
[112].
Conclusion
In short, the evolution of impedimetric immunosensor plat-
forms has been analysed for different types of pathogens. 
Parameters of strong importance such as LOD, detection 
time and sample volume have been discussed and com-
pared. Alternative to classical macro-sized electrodes such 
as IDAM or SPE, the introduction of nanostructures such as 
nanoparticles or nanoporous membranes and the insertion 
of the biosensor into a microfluidic chip have been relevant 
modifications to improve these platforms. Successful evolu-
tion of biosensors is occurring and currently diagnostic tech-
niques are becoming replaced. All biosensors described are 
indicated in Table 1. Nevertheless, limitations such as the 
high cost of the electrodes and antibodies as well as repro-
ducibility still remain a challenge when dealing with large 
scale applications. As a consequence, new antibody derived 
proteins such as nanobodies or non-antibody proteins such 
as Affimers are being investigated in this field.
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Table 1  (continued)
Immunosensor 
electrode
Analyte Immobilisation step LOD Sample volume Detection time References




0.29 pg/mL _ _ [105]
Oxidised GCE DHEAS ox-GCE/AuNPs-ARG/
Ab/EDC/NHS/BSA





0.045 ng/mL 20 μL 1 h [110]
Au Rabbit IgG Ptyr/Sulfo-SMCC/Nano-
body
666 fM 10 μL 30 min [111]
Au IDμE Her4 tumour protein Cys-Her4 Affimer/PBS-
tween 20 based start-
ing block (SB)/Her4
< 1 pM in buffer 
and in serum
_ 30 min [112]
Different components, steps and features of the biosensors are showed, namely: immunosensor electrode, analyte, immobilisation step, LOD and 
sample volume
1,6HDT 1,6-hexanedithiol, 11M1UD 11-Mercapto-1-undecanol, 16MHDA 16-Mercaptohexadecanoic, 2M2P 2-methyl-2-propanethiol, Ab 
antibody, AEE 2-(2-aminoethoxy) ethanol, APTES 3-aminopropyltriethoxy silane, AuNP@SiO2 silica coated gold nanoparticles, bTB bovine 
tuberculosis, BCNT-IL bamboo-like multiwall carbon nanotubes-ionic liquid, BSA bovine serum albumina, BT biotin, CA-125 cancer antigen 
125, ConA concanavalin A, CS chitosan, cTnI Cardiac troponin I, DHEAS dehydroepiandrosterone sulfate, DIEA N,N-diisopropylethylamine, 
DTSP 3-dithiobis-(sulfosuccinimidyl-propionate), EA ethanolamine, ECD epichlorohydrin, EG3SH tri(ethylene glycol), EGFR epidermal growth 
factor, G-AuNPs Graphene gold nanoparticles, GCD glassy carbon disc, GLU glutaraldehyde, GPMS (3-glycidoxypropyl)trimethoxysilane, 
Cys cysteamine, HA hyaluronic acid, hTB human tuberculosis, IDμE interdigitated micro-electrode, MACA mercaptoacetic acid, Mb myoglo-
bin, MBA 4-mercaptobenzoic acid, MDM2 murine double minute 2, MH 6-mercapto-1-hexanol, MHDA mercaptohexadecanoic, MgNbs mag-
netic nanobeads, MgNPs magnetic nanoparticles, MNAC magnetic nanoparticle–antibody conjugates, MPA 3-mercapto propionic acid, MUA 
mercaptoundecanoic acid, MWCNT multi-walled carbon nanotube, NAM nanoporous alumina membrane, NA neutravidin, PAMAM polyami-
doamine, PANI polyaniline, PDITC 1,4-phenylene diisothiocyanate, PEG-thiol carboxy-thiolpolyethyleneglycol, PEI polyethyleneimine, PFP 
2,3,4,5,6-pentafluorophenol, PoPD poly (ortho-phenylenediamine; PP3CA: poly(pyrrole-3-carboxylic acid), PSA prostate-specific antigen, PSSA 
polystyrene sulphonic acid, Ptyr polytyramine, QDs quantum dots, rGO reduced graphene oxide, rGOP reduced graphene oxide paper, RGS 
reduced graphene sheets, SA streptavidin, sLOX-1 soluble lectin-like oxidized low-density lipoprotein receptor-1, SPCE screen-printed carbon 
electrode, SPE screen-printed electrode, SPIE screen-printed interdigitated electrode, Sulfo-SMCC sulfosuccinimidyl 4-[N-maleimidomethyl] 
cyclohexane-1-carboxylate, SWCN single-walled carbon nanotube, TMB 3,3′,5,5′-tetramethyl benzidine, VACNT vertically aligned carbon nano-
tube, WGA wheat germ agglutinin
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adaptation, distribution and reproduction in any medium or format, 
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article are included in the article’s Creative Commons licence, unless 
indicated otherwise in a credit line to the material. If material is not 
included in the article’s Creative Commons licence and your intended 
use is not permitted by statutory regulation or exceeds the permitted 
use, you will need to obtain permission directly from the copyright 
holder. To view a copy of this licence, visit http://creat iveco mmons 
.org/licen ses/by/4.0/.
References
 1. Aslam B et al (2018) Antibiotic resistance: a rundown of a global 
crisis. Infect Drug Resist 11:1645–1658
 2. Joung CK, Kim HN, Im HC, Kim HY, Oh MH, Kim YR (2012) 
Ultra-sensitive detection of pathogenic microorganism using 
surface-engineered impedimetric immunosensor. Sens Actua-
tors B Chem 161(1):824–831
 3. Malvano F, Pilloton R, Albanese D (2018) Sensitive detection 
of Escherichia coli O157:H7 in food products by impedimetric 
immunosensors. Sensors (Switzerland) 18(7):1–11
 4. Mantzila AG, Maipa V, Prodromidis MI (2008) Development of 
a faradic impedimetric immunosensor for the detection of Sal-
monella typhimurium in milk. Anal Chem 80(4):1169–1175
 5. Tiede C et al (2017) Affimer proteins are versatile and renewable 
affinity reagents. Elife 6(c):1–35
 6. Weiss S, Millner P, Nelson A (2005) Monitoring protein binding 
to phospholipid monolayers using electrochemical impedance 
spectroscopy. Electrochim Acta 50(21):4248–4256
 7. O’Neill (2016) Tackling drug-resistant infections globally: Final 
report and recommendations. Review on antimicrobial resist-
ance. https ://amrre view.org/sites /defau lt/files /16051 8_Final 
%20pap er_with%20cov er.pdf. Accessed May 2016
 8. Bursle E, Robson J (2016) Non-culture methods for detecting 
infection. Aust Prescr 39(5):171–175
 9. Sakamoto S et al (2018) Enzyme-linked immunosorbent assay for 
the quantitative/qualitative analysis of plant secondary metabo-
lites. J Nat Med 72(1):32–42
 10. Croxen MA, Law RJ, Scholz R, Keeney KM, Wlodarska M, Fin-
lay BB (2013) Recent advances in understanding enteric patho-
genic Escherichia coli. Clin Microbiol Rev 26(4):822–880
 11. Douterelo I, Boxall JB, Deines P, Sekar R, Fish KE, Biggs CA 
(2014) Methodological approaches for studying the microbial 
ecology of drinking water distribution systems. Water Res 
65:134–156
 12. Zhao X, Li M, Xu Z (2018) Detection of foodborne pathogens 
by surface enhanced Raman spectroscopy. Front Microbiol 
9(JUN):1–13
 13. Rushworth JV, Hirst NA, Goode JA, Pike D, Ahmed A, Millner P 
(2013) Impedimetric biosensors for medical applications: current 
progress and challenges. ASME, New York
 14. Clark LC, Lyons C (1962) Electrode systems for continu-
ous monitoring in cardiovascular surgery. Ann N Y Acad Sci 
102(1):29–45
 15. Oblath EA, Henley WH, Alarie JP, Ramsey JM (2013) A micro-
fluidic chip integrating DNA extraction and real-time PCR for 
the detection of bacteria in saliva. Lab Chip 13(7):1325–1332
 16. Chowdhury AD, Ganganboina AB, Park EY, An Doong R (2018) 
Impedimetric biosensor for detection of cancer cells employing 
carbohydrate targeting ability of Concanavalin A. Biosens Bio-
electron 122(August):95–103
 17. Wilson GS, Gifford R (2005) Biosensors for real-time in vivo 
measurements. Biosens Bioelectron 20(12):2388–2403
 18. van Oss CJ, Good RJ, Chaudhury MK (2002) Nature of the 
antigen–antibody interaction. J Chromatogr B Biomed Sci Appl 
376:111–119
 19. Monošík R, Streďanský M, Šturdík E (2012) Biosensors—clas-
sification, characterization and new trends. Acta Chim Slovaca 
5(1):109–120
 20. Yan XF, Wang MH, An D (2011) Progress of interdigitated array 
microelectrodes based impedance immunosensor. Fenxi Huaxue/
Chin J Anal Chem 39(10):1601–1610
 21. Ligler F, Taitt C (2002) Optical biosensors: present & future. 
Elsevier, Oxford
 22. Borisov SM, Wolfbeis OS (2008) Optical biosensors. Chem Rev 
108(2):423–461
 23. Fan X, White IM, Shopova SI, Zhu H, Suter JD, Sun Y (2008) 
Sensitive optical biosensors for unlabeled targets: a review. Anal 
Chim Acta 620(1–2):8–26
 24. Homola J, Yee SS, Gauglitz G  (1999) Surface plasmon reso-
nance sensors: review. Sens Actuators B Chem 54(1–2):3–15
 25. Arlett JL, Myers EB, Roukes ML (2011) Comparative advantages 
of mechanical biosensors. Nat Nanotechnol 6(4):203–215
 26. Bard AJ, Faulkner LR (2001) Electrochemical methods, 2nd edn. 
Wiley, New York
 27. Koren ME, Papamiditriou C (2013) Spirituality of staff nurses: 
application of modeling and role modeling theory. Holist Nurs 
Pract 27(1):37–44
 28. Chaubey A, Malhotra BD (2002) Review mediated biosensors. 
Biosens Bioelectron 7:441–456
 29. Pisoschi AM (2016) Potentiometric biosensors: concept and 
analytical applications—an editorial. Biochem Anal Biochem 
5(3):19–20
 30. Barlett PN, Cooper JM (1993) A review of the immobilization 
of enzymes in electropolymerized films. J Electroanal Chem 
362(1–2):1–12
 31. Gottschalk A, Breulmann M, Fetter E, Kretschmer K, Bastian M 
(2006) PVC noch ‘heier’ gemacht. Kunststoffe Int 96(7):48–50
 32. Wang J (2001) Glucose biosensors: 40 years of advances and 
challenges. Electroanalysis 13(12):983–988
 33. Metkar SK, Girigoswami K (2019) Diagnostic biosensors in 
medicine—a review. Biocatal Agric Biotechnol 17:271–283
 34. Vakurov A, Pchelintsev NA, Forde J, ’Fgin C, Gibson T, Millner 
P (2009) The preparation of size-controlled functionalized poly-
meric nanoparticles in micelles. Nanotechnology 20(29):295605
 35. Tothill IE, Newman JD, White SF, Turner APF (1997) Monitor-
ing of the glucose concentration during microbial fermentation 
using a novel mass-producible biosensor suitable for on-line use. 
Enzyme Microb Technol 20(8):590–596
 36. Hirst NA, Hazelwood LD, Jayne DG, Millner PA (2013) An 
amperometric lactate biosensor using  H2O2 reduction via a Prus-
sian Blue impregnated poly(ethyleneimine) surface on screen 
printed carbon electrodes to detect anastomotic leak and sepsis. 
Sens Actuators B Chem 186:674–680
 37. Chiang WH, Chen PY, Nien PC, Ho KC (2011) Amperometric 
detection of cholesterol using an indirect electrochemical oxida-
tion method. Steroids 76(14):1535–1540
 38. Lin J et al (2015) An impedance immunosensor based on low-
cost microelectrodes and specific monoclonal antibodies for 
rapid detection of avian influenza virus H5N1 in chicken swabs. 
Biosens Bioelectron 67:546–552
 39. Randviir EP, Banks CE (2013) Electrochemical impedance 
spectroscopy: an overview of bioanalytical applications. Anal 
Methods 5(5):1098–1115
 40. Dinçkaya E, Kinik Ö, Sezgintürk MK, Altuĝ Ç, Akkoca A (2011) 
Development of an impedimetric aflatoxin M1 biosensor based 
361Medical Microbiology and Immunology (2020) 209:343–362 
1 3
on a DNA probe and gold nanoparticles. Biosens Bioelectron 
26(9):3806–3811
 41. Ahmed A, Rushworth JV, Wright JD, Millner PA (2013) Novel 
impedimetric immunosensor for detection of pathogenic bac-
teria Streptococcus pyogenes in human saliva. Anal Chem 
85(24):12118–12125
 42. Conroy PJ, Hearty S, Leonard P, O’Kennedy RJ (2009) Antibody 
production, design and use for biosensor-based applications. 
Semin Cell Dev Biol 20(1):10–26
 43. Song S, Wang L, Li J, Fan C, Zhao J (2008) Aptamer-based 
biosensors. TrAC Trends Anal Chem 27(2):108–117
 44. Tiede C et al (2014) Adhiron: a stable and versatile peptide dis-
play scaffold for molecular recognition applications. Protein Eng 
Des Sel 27(5):145–155
 45. Hou L, Cui Y, Xu M, Gao Z, Huang J, Tang D (2013) Graphene 
oxide-labeled sandwich-type impedimetric immunoassay with 
sensitive enhancement based on enzymatic 4-chloro-1-naphthol 
oxidation. Biosens Bioelectron 47:149–156
 46. Kokkinos C, Economou A, Prodromidis MI (2016) Electrochemi-
cal immunosensors: critical survey of different architectures and 
transduction strategies. TrAC Trends Anal Chem 79:88–105
 47. Bahadir EB, Sezgintürk MK (2016) A review on impedimetric 
biosensors. Artif Cells Nanomed Biotechnol 44(1):248–262
 48. Alshaaer M, Shqair M, Abdelwahed HG, Abuhasel K, Toro MZ 
(2017) Stabilization of heavy oil fly ash (HFO) for construction 
and environmental purposes. Int J Appl Eng Res 12(4):488–497
 49. Guan J-G, Miao Y-Q, Zhang Q-J (2004) Impedimetric biosen-
sors. J Biosci Bioeng 97(4):219–226
 50. Lvovich VF (2012) Impedance spectroscopy: applications to 
electrochemical and dielectric phenomena. Wiley, New York
 51. Rushworth JV, Ahmed A, Griffiths HH, Pollock NM, Hooper 
NM, Millner PA (2014) A label-free electrical impedimetric 
biosensor for the specific detection of Alzheimer’s amyloid-beta 
oligomers. Biosens Bioelectron 56:83–90
 52. Ciani I et al (2012) Development of immunosensors for direct 
detection of three wound infection biomarkers at point of care 
using electrochemical impedance spectroscopy. Biosens Bioel-
ectron 31(1):413–418
 53. Wang Y, Ping J, Ye Z, Wu J, Ying Y (2013) Impedimetric immu-
nosensor based on gold nanoparticles modified graphene paper 
for label-free detection of Escherichia coli O157: H7. Biosens 
Bioelectron 49:492–498
 54. Varshney M, Li Y, Srinivasan B, Tung S (2007) A label-free, 
microfluidics and interdigitated array microelectrode-based 
impedance biosensor in combination with nanoparticles immu-
noseparation for detection of Escherichia coli O157:H7 in food 
samples. Sens Actuators B Chem 128(1):99–107
 55. Samiei E, Tabrizian M, Hoorfar M (2016) A review of digital 
microfluidics as portable platforms for lab-on a-chip applica-
tions. Lab Chip 16(13):2376–2396
 56. Varshney M, Li Y (2009) Interdigitated array microelectrodes 
based impedance biosensors for detection of bacterial cells. Bio-
sens Bioelectron 24(10):2951–2960
 57. Kim J, Woo YY, Moon J, Kim B (2008) A new wideband adap-
tive digital predistortion technique employing feedback lineariza-
tion. IEEE Trans Microw Theory Tech 56(2):385–392
 58. Solanki PR et al (2010) Self-assembled monolayer based impedi-
metric platform for food borne mycotoxin detection. Nanoscale 
2(12):2811–2817
 59. Tan F et al (2011) A PDMS microfluidic impedance immunosen-
sor for E. coli O157:H7 and Staphylococcus aureus detection via 
antibody-immobilized nanoporous membrane. Sens Actuators B 
Chem 159(1):328–335
 60. La Flamme KE et  al (2007) Biocompatibility of nanopo-
rous alumina membranes for immunoisolation. Biomaterials 
28(16):2638–2645
 61. Joung CK, Kim HN, Lim MC, Jeon TJ, Kim HY, Kim YR (2013) 
A nanoporous membrane-based impedimetric immunosensor for 
label-free detection of pathogenic bacteria in whole milk. Bios-
ens Bioelectron 44(1):210–215
 62. Chowdhury AD, De A, Chaudhuri CR, Bandyopadhyay K, Sen P 
(2012) Label free polyaniline based impedimetric biosensor for 
detection of E. coli O157:H7 bacteria. Sens Actuators B Chem 
171–172:916–923
 63. Huang CC, Chang HT (2006) Selective gold-nanoparticle-based 
‘turn-on’ fluorescent sensors for detection of mercury(II) in aque-
ous solution. Anal Chem 78(24):8332–8338
 64. Chen K et al (2012) Hg(II) ion detection using thermally reduced 
graphene oxide decorated with functionalized gold nanoparticles. 
Anal Chem 84(9):4057–4062
 65. Wan J, Ai J, Zhang Y, Geng X, Gao Q, Cheng Z (2016) Signal-off 
impedimetric immunosensor for the detection of Escherichia coli 
O157:H7. Sci Rep 6:2–7
 66. Li Z, Fu Y, Fang W, Li Y (2015) Electrochemical impedance 
immunosensor based on self-assembled monolayers for rapid 
detection of Escherichia coli O157:H7 with signal amplification 
using lectin. Sensors (Switzerland) 15(8):19212–19224
 67. Wang R, Lum J, Callaway Z, Lin J, Bottje W, Li Y (2015) A 
label-free impedance immunosensor using screen-printed inter-
digitated electrodes and magnetic nanobeads for the detection of 
E. coli O157:H7. Biosensors 5(4):791–803
 68. Barreiros dos Santos M et al (2015) Label-free ITO-based immu-
nosensor for the detection of very low concentrations of patho-
genic bacteria. Bioelectrochemistry 101:146–152
 69. Lu L, Chee G, Yamada K, Jun S (2013) Electrochemical imped-
ance spectroscopic technique with a functionalized microwire 
sensor for rapid detection of foodborne pathogens. Biosens Bio-
electron 42(1):492–495
 70. Dougan G, Baker S (2014) Salmonella enterica Serovar Typhi 
and the pathogenesis of typhoid fever. Annu Rev Microbiol 
68(1):317–336
 71. Pournaras AV, Koraki T, Prodromidis MI (2008) Development 
of an impedimetric immunosensor based on electropolymer-
ized polytyramine films for the direct detection of Salmonella 
typhimurium in pure cultures of type strains and inoculated real 
samples. Anal Chim Acta 624(2):301–307
 72. Farka Z, Juřík T, Pastucha M, Kovář D, Lacina K, Skládal P 
(2016) Rapid immunosensing of Salmonella typhimurium using 
electrochemical impedance spectroscopy: the effect of sample 
treatment. Electroanalysis 28(8):1803–1809
 73. Nguyen PD, Tran TB, Nguyen DTX, Min J (2014) Magnetic 
silica nanotube-assisted impedimetric immunosensor for the 
separation and label-free detection of Salmonella typhimurium. 
Sens Actuators B Chem 197:314–320
 74. Wen T, Wang R, Sotero A, Li Y (2017) A portable impedance 
immunosensing system for rapid detection of Salmonella typh-
imurium. Sensors (Switzerland) 17(9):1–15
 75. Pal N, Sharma S, Gupta S (2016) Sensitive and rapid detection 
of pathogenic bacteria in small volumes using impedance spec-
troscopy technique. Biosens Bioelectron 77:270–276
 76. Wan Y, Zhang D, Hou B (2009) Monitoring microbial popula-
tions of sulfate-reducing bacteria using an impedimetric immu-
nosensor based on agglutination assay. Talanta 80(1):218–223
 77. Lis H, Sharon N (1998) Lectins: carbohydrate-specific proteins 
that mediate cellular recognition. Chem Rev 98(2):637–674
 78. Wan Y, Zhang D, Wang Y, Hou B (2010) A 3D-impedimetric 
immunosensor based on foam Ni for detection of sulfate-reduc-
ing bacteria. Electrochem Commun 12(2):288–291
 79. Wan Y, Lin Z, Zhang D, Wang Y, Hou B (2011) Impedimetric 
immunosensor doped with reduced graphene sheets fabricated 
by controllable electrodeposition for the non-labelled detection 
of bacteria. Biosens Bioelectron 26(5):1959–1964
362 Medical Microbiology and Immunology (2020) 209:343–362
1 3
 80. Yang J, Deng S, Lei J, Ju H, Gunasekaran S (2011) Electrochemi-
cal synthesis of reduced graphene sheet-AuPd alloy nanoparti-
cle composites for enzymatic biosensing. Biosens Bioelectron 
29(1):159–166
 81. Drevets DA, Bronze MS (2008) Listeria monocytogenes: epi-
demiology, human disease, and mechanisms of brain invasion. 
FEMS Immunol Med Microbiol 53(2):151–165
 82. Wang R et al (2008)  TiO2 nanowire bundle microelectrode based 
impedance immunosensor for rapid and sensitive detection of 
Listeria monocytogenes. Nano Lett 8(9):2625–2631
 83. Kanayeva DA et  al (2012) Efficient separation and sensi-
tive detection of Listeria monocytogenes using an impedance 
immunosensor based on magnetic nanoparticles, a microflu-
idic chip, and an interdigitated microelectrode. J Food Prot 
75(11):1951–1959
 84. Bekir K et al (2015) An investigation of the well-water qual-
ity: immunosensor for pathogenic Pseudomonas aeruginosa 
detection based on antibody-modified poly(pyrrole-3 carboxylic 
acid) screen-printed carbon electrode. Environ Sci Pollut Res 
22(23):18669–18675
 85. Bekir K et al (2015) Electrochemical impedance immunosensor 
for rapid detection of stressed pathogenic Staphylococcus aureus 
bacteria. Environ Sci Pollut Res 22(20):15796–15803
 86. Wang R et al (2009) Interdigitated array microelectrode based 
impedance immunosensor for detection of avian influenza virus 
H5N1. Talanta 79(2):159–164
 87. Lin D, Tang T, Harrison DJ, Lee WE, Jemere AB (2015) A 
regenerating ultrasensitive electrochemical impedance immu-
nosensor for the detection of adenovirus. Biosens Bioelectron 
68:129–134
 88. Jarocka U, Wasowicz M, Radecka H, Malinowski T, Michal-
czuk L, Radecki J (2011) Impedimetric immunosensor for 
detection of plum pox virus in plant extracts. Electroanalysis 
23(9):2197–2204
 89. Qi X, Chen T, Lu D, Chen B (2017) Graphene-Au nanoparticle 
based electrochemical immunosensor for fish pathogen Aphano-
myces invadans detection. Fuller Nanotub Carbon Nanostruct 
25(1):12–16
 90. Lennon RP, Claussen KA, Kuersteiner KA (2018) State of the 
heart: an overview of the disease burden of cardiovascular dis-
ease from an epidemiologic perspective. Prim Care Clin Off 
Pract 45(1):1–15
 91. Sharma RV, Tanwar VK, Mishra SK, Biradar AM (2010) Electro-
chemical impedance immunosensor for the detection of cardiac 
biomarker Myogobin (Mb) in aqueous solution. Thin Solid Films 
519(3):1167–1170
 92. Mishra SK, Srivastava AK, Kumar D (2014) Bio-functionalized 
Pt nanoparticles based electrochemical impedance immunosen-
sor for human cardiac myoglobin. RSC Adv 4(41):21267–21276
 93. Khan R, Pal M, Kuzikov AV, Bulko T, Suprun EV, Shumyantseva 
VV (2016) Impedimetric immunosensor for detection of cardio-
vascular disorder risk biomarker. Mater Sci Eng C 68:52–58
 94. Thostenson ET, Ren Z, Chou TW (2001) Advances in the sci-
ence and technology of carbon and their composites: a review. 
Compos Sci Technol 61(13):1899–1912
 95. Billah MM, Hays HCW, Hodges CS, Ponnambalam S, Vohra R, 
Millner PA (2012) Mixed self-assembled monolayer (mSAM) 
based impedimetric immunosensors for cardiac troponin i (cTnI) 
and soluble lectin-like oxidized low-density lipoprotein recep-
tor-1 (sLOX-1). Sens Actuators B Chem 173:361–366
 96. Akter R, Jeong B, Lee YM, Choi JS, Rahman MA (2017) Femto-
molar detection of cardiac troponin I using a novel label-free and 
reagent-free dendrimer enhanced impedimetric immunosensor. 
Biosens Bioelectron 91(January):637–643
 97. Bourigua S et al (2010) Impedimetric immunosensor based on 
SWCNT-COOH modified gold microelectrodes for label-free 
detection of deep venous thrombosis biomarker. Biosens Bioel-
ectron 26(4):1278–1282
 98. Asav E, Sezgintürk MK (2014) A novel impedimetric dispos-
able immunosensor for rapid detection of a potential cancer bio-
marker. Int J Biol Macromol 66:273–280
 99. Elshafey R, Tavares AC, Siaj M, Zourob M (2013) Electrochemi-
cal impedance immunosensor based on gold nanoparticles-pro-
tein G for the detection of cancer marker epidermal growth factor 
receptor in human plasma and brain tissue. Biosens Bioelectron 
50:143–149
 100. Dall’era MA et al (2008) Active surveillance for early-stage 
prostate cancer: review of the current literature. Cancer 
112(8):1650–1659
 101. Gutiérrez-Zúñiga GG, Hernández-López JL (2016) Sensitivity 
improvement of a sandwich-type ELISA immunosensor for the 
detection of different prostate-specific antigen isoforms in human 
serum using electrochemical impedance spectroscopy and an 
ordered and hierarchically organized interfacial supramolecular 
architecture. Anal Chim Acta 902:97–106
 102. Liu S, Han M (2005) Synthesis, functionalization, and bioconju-
gation of monodisperse, silica-coated gold nanoparticles: robust 
bioprobes. Adv Funct Mater 15(6):961–967
 103. Petryayeva E, Algar WR, Medintz IL (2013) Quantum dots in 
bioanalysis: a review of applications across various platforms 
for fluorescence spectroscopy and imaging. Appl Spectrosc 
67(3):215–252
 104. Johari-Ahar M et al (2015) An ultra-sensitive impedimetric 
immunosensor for detection of the serum oncomarker CA-125 
in ovarian cancer patients. Nanoscale 7(8):3768–3779
 105. Elshafey R, Tlili C, Abulrob A, Tavares AC, Zourob M (2013) 
Label-free impedimetric immunosensor for ultrasensitive detec-
tion of cancer marker Murine double minute 2 in brain tissue. 
Biosens Bioelectron 39(1):220–225
 106. Lima D et al (2019) Label-free impedimetric immunosensor 
based on arginine-functionalized gold nanoparticles for detection 
of DHEAS, a biomarker of pediatric adrenocortical carcinoma. 
Biosens Bioelectron 133(February):86–93
 107. Cui H et al (2013) An AC electrokinetic impedance immu-
nosensor for rapid detection of tuberculosis. Analyst 
138(23):7188–7196
 108. Montrose A, Cargou S, Nepveu F, Manczak R, Gué AM, Rey-
bier K (2013) Impedimetric immunosensor for the detection of 
circulating pro-inflammatory monocytes as infection markers. 
Biosens Bioelectron 49:305–311
 109. Steeland S, Vandenbroucke RE, Libert C (2016) Nanobodies as 
therapeutics: big opportunities for small antibodies. Drug Discov 
Today 21(7):1076–1113
 110. Li G et  al (2016) Generation of small single domain nano-
body binders for sensitive detection of testosterone by electro-
chemical impedance spectroscopy. ACS Appl Mater Interfaces 
8(22):13830–13839
 111. Goode J, Dillon G, Millner PA (2016) The development and 
optimisation of nanobody based electrochemical immunosensors 
for IgG. Sens Actuators B Chem 234:478–484
 112. Zhurauski P et al (2018) Sensitive and selective Affimer-func-
tionalised interdigitated electrode-based capacitive biosensor for 
Her4 protein tumour biomarker detection. Biosens Bioelectron 
108:1–8
Publisher’s Note Springer Nature remains neutral with regard to 
jurisdictional claims in published maps and institutional affiliations.
